| 2020 |
| 09/01 | 1,086 | 1,095 | 1,071 | 1,084 | -0.09% | 57,400 | 615億8647万 | +3.24% |
| 08/31 | 1,095 | 1,117 | 1,078 | 1,085 | +1.5% | 78,500 | 616億4329万 | +3.24% |
| 08/28 | 1,065 | 1,117 | 1,051 | 1,069 | +1.52% | 176,300 | 607億3426万 | +1.81% |
| 08/27 | 11:00 Dalton Chemical Laboratories, Inc.におけるVIDO-InterVacとの新型コロナウイルス感染症（COVID-19）ワクチン開発の提携に関するお知らせ |
| 08/27 | 1,054 | 1,245 | 1,029 | 1,053 | -0.47% | 631,600 | 598億2523万 | +0.29% |
| 08/26 | 1,040 | 1,061 | 1,030 | 1,058 | +1.24% | 37,300 | 601億931万 | +0.67% |
| 08/25 | 1,046 | 1,063 | 1,035 | 1,045 | -0.29% | 49,800 | 593億7072万 | -0.57% |
| 08/24 | 1,031 | 1,048 | 1,029 | 1,048 | +1.65% | 42,600 | 595億4116万 | -0.38% |
| 08/21 | 1,050 | 1,053 | 1,022 | 1,031 | -1.34% | 30,000 | 585億7532万 | -2.09% |
| 08/20 | 1,029 | 1,046 | 1,025 | 1,045 | +1.36% | 31,400 | 593億7072万 | -0.95% |
| 08/19 | 1,034 | 1,040 | 1,025 | 1,031 | -0.29% | 21,200 | 585億7532万 | -2.46% |
| 08/18 | 1,042 | 1,056 | 1,028 | 1,034 | -1.24% | 52,600 | 587億4577万 | -2.08% |
| 08/17 | 1,054 | 1,054 | 1,034 | 1,047 | -0.66% | 23,200 | 594億8435万 | -1.04% |
| 08/14 | 1,068 | 1,070 | 1,053 | 1,054 | -1.5% | 30,700 | 598億8205万 | -0.47% |
| 08/13 | 1,077 | 1,077 | 1,056 | 1,070 | -0.47% | 48,700 | 607億9107万 | +0.75% |
| 08/12 | 1,049 | 1,075 | 1,048 | 1,075 | +2.38% | 53,000 | 610億7514万 | +1.03% |
| 08/11 | 1,013 | 1,054 | 1,011 | 1,050 | +4.06% | 55,900 | 596億5479万 | -1.5% |
| 08/07 | 1,030 | 1,036 | 1,003 | 1,009 | -1.94% | 44,400 | 573億2541万 | -5.52% |
| 08/06 | 1,019 | 1,040 | 1,011 | 1,029 | +0.49% | 52,100 | 584億6170万 | -3.92% |
| 08/05 | 1,032 | 1,046 | 1,015 | 1,024 | -1.16% | 45,600 | 581億7763万 | -4.74% |
| 08/04 | 1,071 | 1,080 | 1,027 | 1,036 | -3.27% | 27,900 | 588億5940万 | -4.16% |
| 08/03 | 991 | 1,088 | 983 | 1,071 | +7.42% | 73,600 | 608億4789万 | -1.38% |
| 07/31 | 15:00 2021年3月期第1四半期決算短信〔日本基準〕(連結) |
| 07/31 | 1,046 | 1,054 | 960 | 997 | -7.08% | 69,600 | 566億4365万 | -8.45% |
| 07/30 | 1,070 | 1,090 | 1,039 | 1,073 | +1.13% | 39,900 | 609億6152万 | -2.01% |
| 07/29 | 1,083 | 1,089 | 1,060 | 1,061 | -1.94% | 26,500 | 602億7975万 | -3.46% |
| 07/28 | 1,092 | 1,100 | 1,076 | 1,082 | -0.92% | 22,900 | 614億7284万 | -1.99% |
| 07/27 | 1,059 | 1,092 | 1,052 | 1,092 | +3.31% | 40,700 | 620億4098万 | -1.53% |
| 07/22 | 1,084 | 1,084 | 1,057 | 1,057 | -2.49% | 27,600 | 600億5249万 | -4.95% |
| 07/21 | 1,054 | 1,091 | 1,053 | 1,084 | +2.26% | 54,500 | 615億8647万 | -2.95% |
| 07/20 | 1,063 | 1,065 | 1,051 | 1,060 | -0.28% | 24,800 | 602億2293万 | -5.36% |
| 07/17 | 1,084 | 1,093 | 1,062 | 1,063 | -1.85% | 30,800 | 603億9338万 | -5.26% |
| 07/16 | 1,071 | 1,089 | 1,071 | 1,083 | +1.5% | 44,900 | 615億2966万 | -3.73% |
| 07/15 | 1,082 | 1,082 | 1,056 | 1,067 | -1.39% | 73,900 | 606億2063万 | -5.32% |
| 07/14 | 1,082 | 1,096 | 1,077 | 1,082 | 0% | 26,500 | 614億7284万 | -4.33% |
| 07/13 | 1,049 | 1,085 | 1,044 | 1,082 | +5.05% | 40,800 | 614億7284万 | -4.5% |
| 07/10 | 10:00 譲渡制限付株式報酬としての自己株式の処分の払込完了に関するお知らせ |
| 07/10 | 1,064 | 1,067 | 1,030 | 1,030 | -3.65% | 70,900 | 585億1851万 | -9.33% |
| 07/09 | 1,081 | 1,086 | 1,069 | 1,069 | -0.93% | 56,400 | 607億3426万 | -6.23% |
| 07/08 | 1,124 | 1,148 | 1,079 | 1,079 | -4.17% | 74,800 | 613億240万 | -5.6% |
| 07/07 | 1,130 | 1,148 | 1,119 | 1,126 | -0.35% | 63,400 | 639億7266万 | -1.75% |
| 07/06 | 1,114 | 1,136 | 1,112 | 1,130 | +1.62% | 46,400 | 641億9992万 | -1.31% |
| 07/03 | 1,096 | 1,115 | 1,096 | 1,112 | +0.54% | 42,000 | 631億7727万 | -2.88% |
| 07/02 | 1,097 | 1,127 | 1,096 | 1,106 | +1.56% | 71,400 | 628億3638万 | -3.49% |
| 07/01 | 1,127 | 1,130 | 1,084 | 1,089 | -3.8% | 81,700 | 618億7054万 | -5.22% |
| 06/30 | 1,170 | 1,173 | 1,132 | 1,132 | -1.91% | 56,800 | 643億1355万 | -1.65% |
| 06/29 | 1,165 | 1,168 | 1,145 | 1,154 | -1.03% | 40,000 | 655億6346万 | +0.35% |
| 06/26 | 17:00 (開示事項の経過)Dalton Chemical Laboratories, Inc.の株式取得(子会社化)の完了及び特定子会社の異動に関するお知らせ |
| 06/26 | 1,148 | 1,171 | 1,148 | 1,166 | +1.92% | 42,500 | 662億4523万 | +1.66% |
| 06/25 | 1,143 | 1,154 | 1,136 | 1,144 | -1.12% | 28,000 | 649億9532万 | 0% |
| 06/24 | 1,171 | 1,171 | 1,155 | 1,157 | -1.45% | 21,900 | 657億3390万 | +1.31% |
| 06/23 | 1,193 | 1,194 | 1,156 | 1,174 | -0.68% | 42,300 | 666億9974万 | +2.98% |
| 06/22 | 1,191 | 1,195 | 1,176 | 1,182 | -1.58% | 32,600 | 671億5425万 | +3.78% |
| 06/19 | 16:00 譲渡制限付株式報酬としての自己株式の処分に関するお知らせ |
| 06/19 | 1,180 | 1,206 | 1,170 | 1,201 | +2.21% | 70,700 | 682億3372万 | +5.63% |
| 06/18 | 1,172 | 1,180 | 1,163 | 1,175 | +0.69% | 35,500 | 667億5655万 | +3.71% |
| 06/17 | 1,158 | 1,180 | 1,154 | 1,167 | +0.43% | 36,900 | 663億204万 | +3.37% |
| 06/16 | 1,138 | 1,163 | 1,121 | 1,162 | +5.06% | 59,600 | 660億1797万 | +3.11% |
| 06/15 | 1,139 | 1,162 | 1,106 | 1,106 | -3.07% | 52,100 | 628億3638万 | -1.78% |
| 06/12 | 1,125 | 1,154 | 1,116 | 1,141 | 0% | 75,100 | 648億2488万 | +1.33% |
| 06/11 | 14:00 変形性関節症治療剤ONO-5704/SI-613の変形性膝関節症患者を対象とした国内第III相臨床試験結果の学会発表に関するお知らせ |
| 06/11 | 1,176 | 1,197 | 1,138 | 1,141 | -2.56% | 109,300 | 648億2488万 | +1.51% |
| 06/10 | 1,149 | 1,177 | 1,135 | 1,171 | +2.81% | 59,400 | 665億2930万 | +4.46% |
| 06/09 | 1,160 | 1,160 | 1,132 | 1,139 | -0.7% | 38,100 | 647億1125万 | +1.97% |
| 06/08 | 1,132 | 1,147 | 1,123 | 1,147 | +1.59% | 28,900 | 651億6576万 | +2.96% |
| 06/05 | 1,140 | 1,142 | 1,120 | 1,129 | -1.05% | 39,600 | 641億4311万 | +1.62% |
| 06/04 | 1,158 | 1,163 | 1,128 | 1,141 | -0.52% | 31,500 | 648億2488万 | +2.79% |
| 06/03 | 1,125 | 1,150 | 1,118 | 1,147 | +3.15% | 65,000 | 651億6576万 | +3.52% |
| 06/02 | 1,129 | 1,129 | 1,110 | 1,112 | -1.42% | 59,700 | 631億7727万 | +0.63% |
| 06/01 | 1,145 | 1,148 | 1,122 | 1,128 | -1.66% | 43,100 | 640億8629万 | +2.17% |
| 05/29 | 1,163 | 1,172 | 1,133 | 1,147 | -1.97% | 96,600 | 651億6576万 | +4.18% |
| 05/28 | 1,149 | 1,172 | 1,135 | 1,170 | +3.27% | 64,800 | 664億7248万 | +6.65% |
| 05/27 | 1,107 | 1,143 | 1,097 | 1,133 | +2.35% | 109,600 | 643億7036万 | +3.56% |
| 05/26 | 1,094 | 1,107 | 1,086 | 1,107 | +1.37% | 59,400 | 628億9320万 | +1.37% |
| 05/25 | 1,099 | 1,100 | 1,082 | 1,092 | +0.09% | 46,500 | 620億4098万 | +0.28% |
| 05/22 | 1,090 | 1,105 | 1,085 | 1,091 | 0% | 55,800 | 619億8417万 | +0.28% |
| 05/21 | 11:00 癒着防止材SI-449のピボタル試験開始に関するお知らせ |
| 05/21 | 1,109 | 1,109 | 1,090 | 1,091 | -1% | 88,100 | 619億8417万 | +0.37% |
| 05/20 | 1,100 | 1,127 | 1,075 | 1,102 | -5% | 146,900 | 626億913万 | +1.19% |
| 05/19 | 16:00 当社株式の大規模買付行為に対する対応策(買収防衛策)の非継続(廃止)に関するお知らせ |
| 05/19 | 16:00 通期連結業績予想値と実績値との差異に関するお知らせ |
| 05/19 | 16:00 2020年3月期決算短信〔日本基準〕(連結) |
| 05/19 | 1,166 | 1,169 | 1,130 | 1,160 | +3.02% | 63,600 | 659億434万 | +6.62% |
| 05/18 | 1,098 | 1,130 | 1,098 | 1,126 | +3.21% | 49,900 | 639億7266万 | +3.68% |
| 05/15 | 1,089 | 1,100 | 1,073 | 1,091 | +0.74% | 20,000 | 619億8417万 | +0.46% |
| 05/14 | 1,125 | 1,125 | 1,083 | 1,083 | -3.73% | 23,500 | 615億2966万 | -0.28% |
| 05/13 | 1,115 | 1,132 | 1,113 | 1,125 | +0.18% | 33,500 | 639億1585万 | +3.69% |
| 05/12 | 1,128 | 1,137 | 1,113 | 1,123 | +0.81% | 23,400 | 638億222万 | +3.89% |
| 05/11 | 1,092 | 1,117 | 1,080 | 1,114 | +2.77% | 50,100 | 632億9089万 | +3.15% |
| 05/08 | 1,076 | 1,085 | 1,060 | 1,084 | +2.17% | 41,800 | 615億8647万 | +0.37% |
| 05/07 | 1,073 | 1,079 | 1,059 | 1,061 | -1.12% | 59,100 | 602億7975万 | -2.03% |
| 05/01 | 1,064 | 1,075 | 1,047 | 1,073 | +0.47% | 38,300 | 609億6152万 | -1.38% |
| 04/30 | 1,105 | 1,106 | 1,064 | 1,068 | -0.93% | 85,400 | 606億7745万 | -1.93% |
| 04/28 | 1,094 | 1,095 | 1,070 | 1,078 | -1.91% | 43,800 | 612億4559万 | -1.01% |
| 04/27 | 18:00 2020年3月期連結決算発表の日程延期に関するお知らせ |
| 04/27 | 1,095 | 1,099 | 1,082 | 1,099 | +0.37% | 33,200 | 624億3868万 | +1.1% |
| 04/24 | 1,092 | 1,096 | 1,065 | 1,095 | +1.2% | 45,600 | 622億1143万 | +0.92% |
| 04/23 | 1,073 | 1,086 | 1,059 | 1,082 | +1.12% | 43,300 | 614億7284万 | +0.19% |
| 04/22 | 1,065 | 1,079 | 1,048 | 1,070 | +0.38% | 41,100 | 607億9107万 | -0.47% |
| 04/21 | 15:00 役員の異動に関するお知らせ |
| 04/21 | 1,045 | 1,071 | 1,045 | 1,066 | +2.01% | 43,000 | 605億6382万 | -0.56% |
| 04/20 | 1,070 | 1,075 | 1,038 | 1,045 | -3.42% | 57,400 | 593億7072万 | -1.88% |
| 04/17 | 1,124 | 1,125 | 1,079 | 1,082 | -1.64% | 55,000 | 614億7284万 | +2.27% |
| 04/16 | 1,032 | 1,101 | 1,032 | 1,100 | +7.42% | 92,200 | 624億9550万 | +4.46% |
| 04/15 | 1,071 | 1,078 | 1,017 | 1,024 | -3.85% | 78,500 | 581億7763万 | -2.29% |
| 04/14 | 1,078 | 1,084 | 1,060 | 1,065 | -1.3% | 60,700 | 605億700万 | +1.72% |
| 04/13 | 1,119 | 1,122 | 1,074 | 1,079 | -3.57% | 35,800 | 613億240万 | +3.35% |
| 04/10 | 1,096 | 1,119 | 1,085 | 1,119 | +1.91% | 47,200 | 635億7497万 | +7.29% |
| 04/09 | 1,105 | 1,113 | 1,077 | 1,098 | -0.9% | 45,900 | 623億8187万 | +5.37% |
| 04/08 | 1,121 | 1,121 | 1,096 | 1,108 | 0% | 63,100 | 629億5001万 | +6.33% |
| 04/07 | 1,113 | 1,113 | 1,078 | 1,108 | +1.28% | 51,500 | 629億5001万 | +6.54% |
| 04/06 | 1,049 | 1,098 | 1,040 | 1,094 | +3.89% | 54,600 | 621億5461万 | +5.19% |
| 04/01 | 15:00 変形性関節症治療剤SI-613の中国における共同開発及び販売提携に関する契約締結のお知らせ |
| 03/31 | 15:00 人事異動に関するお知らせ |
